GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Sold by Thompson Davis & CO. Inc.

Thompson Davis & CO. Inc. trimmed its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 52.4% in the 3rd quarter, HoldingsChannel reports. The firm owned 2,536 shares of the company’s stock after selling 2,795 shares during the period. Thompson Davis & CO. Inc.’s holdings in GE HealthCare Technologies were worth $238,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of GEHC. Pathway Financial Advisers LLC purchased a new position in shares of GE HealthCare Technologies in the 1st quarter valued at about $25,000. LGT Financial Advisors LLC increased its position in shares of GE HealthCare Technologies by 1,673.3% in the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock valued at $25,000 after purchasing an additional 251 shares during the last quarter. Fred Alger Management LLC acquired a new stake in shares of GE HealthCare Technologies in the 2nd quarter valued at $26,000. Capital Performance Advisors LLP acquired a new stake in shares of GE HealthCare Technologies in the 3rd quarter valued at $26,000. Finally, Ashton Thomas Securities LLC purchased a new stake in shares of GE HealthCare Technologies during the 3rd quarter worth $26,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Insiders Place Their Bets

In other news, CEO Roland Rott sold 3,577 shares of the stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total value of $309,338.96. Following the completion of the transaction, the chief executive officer now owns 24,298 shares in the company, valued at $2,101,291.04. This trade represents a 12.83 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.27% of the stock is currently owned by company insiders.

GE HealthCare Technologies Stock Performance

Shares of GEHC opened at $82.52 on Wednesday. The stock has a market capitalization of $37.70 billion, a P/E ratio of 22.67, a P/E/G ratio of 2.93 and a beta of 1.24. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.98 and a current ratio of 1.23. GE HealthCare Technologies Inc. has a 1 year low of $66.39 and a 1 year high of $94.55. The company’s fifty day moving average is $88.59 and its two-hundred day moving average is $83.57.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.06 by $0.08. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The firm had revenue of $4.86 billion during the quarter, compared to analysts’ expectations of $4.87 billion. During the same period in the prior year, the company posted $0.99 earnings per share. The firm’s revenue for the quarter was up .9% on a year-over-year basis. On average, sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.29 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were issued a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a yield of 0.15%. The ex-dividend date was Friday, October 18th. GE HealthCare Technologies’s dividend payout ratio is presently 3.30%.

Analysts Set New Price Targets

Several research firms recently commented on GEHC. Stifel Nicolaus increased their target price on GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a report on Monday, September 30th. Redburn Atlantic raised GE HealthCare Technologies to a “strong-buy” rating in a report on Thursday, August 1st. Evercore ISI boosted their price objective on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 1st. JPMorgan Chase & Co. assumed coverage on shares of GE HealthCare Technologies in a research note on Monday, September 9th. They set a “neutral” rating and a $90.00 price target on the stock. Finally, UBS Group downgraded shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and decreased their price objective for the company from $84.00 to $74.00 in a research note on Thursday, September 26th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, GE HealthCare Technologies has an average rating of “Moderate Buy” and an average target price of $94.36.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.